The Interplay Between Bone and Glucose Metabolism

被引:150
作者
Cipriani, Cristiana [1 ]
Colangelo, Luciano [1 ]
Santori, Rachele [1 ]
Renella, Mario [1 ]
Mastrantonio, Monia [1 ]
Minisola, Salvatore [1 ]
Pepe, Jessica [1 ]
机构
[1] Sapienza Univ Rome, Dept Internal Med & Med Disciplines, Rome, Italy
关键词
glucose; bone; metabolism; diabetes; osteoporosis; fracture; TYPE-2; DIABETES-MELLITUS; MINERAL DENSITY; INSULIN-RESISTANCE; FRACTURE RISK; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; RECEPTOR ACTIVATOR; ADIPOSE-TISSUE; LIPOCALIN; MARROW FAT;
D O I
10.3389/fendo.2020.00122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The multiple endocrine functions of bone other than those related to mineral metabolism, such as regulation of insulin sensitivity, glucose homeostasis, and energy metabolism, have recently been discovered. In vitro and murine studies investigated the impact of several molecules derived from osteoblasts and osteocytes on glucose metabolism. In addition, the effect of glucose on bone cells suggested a mutual cross-talk between bone and glucose homeostasis. In humans, these mechanisms are the pivotal determinant of the skeletal fragility associated with both type 1 and type 2 diabetes. Metabolic abnormalities associated with diabetes, such as increase in adipose tissue, reduction of lean mass, effects of hyperglycemia per se, production of the advanced glycation end products, diabetes-associated chronic kidney disease, and perturbation of the calcium-PTH-vitamin D metabolism, are the main mechanisms involved. Finally, there have been multiple reports of antidiabetic drugs affecting the skeleton, with differences among basic and clinical research data, as well as of anti-osteoporosis medication influencing glucose metabolism. This review focuses on the aspects linking glucose and bone metabolism by offering insight into the most recent evidence in humans.
引用
收藏
页数:9
相关论文
共 118 条
[81]   Bone mass and bone modelling markers in hypertensive postmenopausal women [J].
Pérez-Castrillón, JL ;
Justo, I ;
Silva, J ;
Sanz, A ;
Igea, R ;
Escudero, P ;
Pueyo, C ;
Diaz, C ;
Hernández, G ;
Dueñas, A .
JOURNAL OF HUMAN HYPERTENSION, 2003, 17 (02) :107-110
[82]   Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy [J].
Perkovic, V. ;
Jardine, M. J. ;
Neal, B. ;
Bompoint, S. ;
Heerspink, H. J. L. ;
Charytan, D. M. ;
Edwards, R. ;
Agarwal, R. ;
Bakris, G. ;
Bull, S. ;
Cannon, C. P. ;
Capuano, G. ;
Chu, P. -L. ;
De Zeeuw, D. ;
Greene, T. ;
Levin, A. ;
Pollock, C. ;
Wheeler, D. C. ;
Yavin, Y. ;
Zhang, H. ;
Zinman, B. ;
Meininger, G. ;
Brenner, B. M. ;
Mahaffey, K. W. ;
McGuire, Darren K. ;
Holman, Rury ;
Home, Philip ;
Scharfstein, Dan ;
Parfrey, Patrick ;
Shahinfar, Shahnaz ;
August, Phyllis ;
Chang, Tara ;
Sinha, Arjun D. ;
Januzzi, James ;
Kolansky, Daniel ;
Amerena, John ;
Hillis, Graham ;
Gorelick, Philip ;
Kissela, Brett ;
Kasner, Scott ;
Lindley, Richard ;
Fulcher, Greg ;
Ounadjela, Souhila ;
Hufert, Karina ;
von Ingersleben, Gabriele ;
Gaglia, Jason ;
Harris, Ronald ;
Hudson, Margo ;
Turchin, Alexander ;
Cheifetz, Adam .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24) :2295-2306
[83]   Vitamin D Supplementation and Prevention of Type 2 Diabetes [J].
Pittas, Anastassios G. ;
Dawson-Hughes, Bess ;
Sheehan, Patricia ;
Ware, James H. ;
Knowler, William C. ;
Aroda, Vanita R. ;
Brodsky, Irwin ;
Ceglia, Lisa ;
Chadha, Chhavi ;
Chatterjee, Ranee ;
Desouza, Cyrus ;
Dolor, Rowena ;
Foreyt, John ;
Fuss, Paul ;
Ghazi, Adline ;
Hsia, Daniel S. ;
Johnson, Karen C. ;
Kashyap, Sangeeta R. ;
Kim, Sun ;
LeBlanc, Erin S. ;
Lewis, Michael R. ;
Liao, Emilia ;
Neff, Lisa M. ;
Nelson, Jason ;
O'Neil, Patrick ;
Park, Jean ;
Peters, Anne ;
Phillips, Lawrence S. ;
Pratley, Richard ;
Raskin, Philip ;
Rasouli, Neda ;
Robbins, David ;
Rosen, Clifford ;
Vickery, Ellen M. ;
Staten, Myrlene .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (06) :520-530
[84]   Impact of pioglitazone on bone mineral density and bone marrow fat content [J].
Pop, L. M. ;
Lingvay, I. ;
Yuan, Q. ;
Li, X. ;
Adams-Huet, B. ;
Maalouf, N. M. .
OSTEOPOROSIS INTERNATIONAL, 2017, 28 (11) :3261-3269
[85]   Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial [J].
Portillo-Sanchez, Paola ;
Bril, Fernando ;
Lomonaco, Romina ;
Barb, Diana ;
Orsak, Beverly ;
Bruder, Jan Marie ;
Cusi, Kenneth .
JOURNAL OF DIABETES, 2019, 11 (03) :223-231
[86]   Lipocalin-2 Expression and Serum Levels as Early Predictors of Type 2 Diabetes Mellitus in Obese Women [J].
Rashad, Nearmeen M. ;
El-Shal, Amal S. ;
Etewa, Rasha L. ;
Wadea, Fady M. .
IUBMB LIFE, 2017, 69 (02) :88-97
[87]   HYPERCALCIURIA OF DIABETES-MELLITUS - ITS AMELIORATION WITH INSULIN [J].
RASKIN, P ;
STEVENSON, MRM ;
BARILLA, DE ;
PAK, CYC .
CLINICAL ENDOCRINOLOGY, 1978, 9 (04) :329-335
[88]   MECHANISMS IN ENDOCRINOLOGY Bone marrow adiposity and bone, a bad romance? [J].
Rharass, Tareck ;
Lucas, Stephanie .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 179 (04) :R165-R182
[89]   Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis [J].
Rucci, Nadia ;
Capulli, Mattia ;
Piperni, Sara Gemini ;
Cappariello, Alfredo ;
Lau, Patrick ;
Frings-Meuthen, Petra ;
Heer, Martina ;
Teti, Anna .
JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (02) :357-368
[90]   Metformin use and risk of fracture: a systematic review and meta-analysis of observational studies [J].
Salari-Moghaddam, A. ;
Sadeghi, O. ;
Keshteli, A. H. ;
Larijani, B. ;
Esmaillzadeh, A. .
OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) :1167-1173